Mylan CEO Bresch: ‘No one’s more frustrated than me’ about EpiPen price furor

Mylan CEO Heather Bresch struggled Thursday to justify the repeated big price hikes of the company’s lifesaving EpiPen devices as criticism continued that Mylan is gouging consumers with a retail cost of more than $600.

“No one’s more frustrated than me,” Bresch told CNBC’s “Squawk Box” on Thursday when she was pressed on the question of why Mylan needed to have such a high price for EpiPens, and why she just didn’t cut their price.

“Everybody should be frustrated,” said Bresch,…Watch the complete interview with embattled Mylan CEO Bresch

Thursday, 25 Aug 2016 | 8:32 AM ET | 18:51

CNBC